Maravai Lifesciences Up Over 30%, on Pace for Largest Percent Increase in Over a Year -- Data Talk
Dow Jones2026/08/19 14:36Maravai Lifesciences Holdings, Inc. Class A (MRVI) is currently at $7.46, up $1.73 or 30.05%
--Would be highest close since Nov. 7, 2024, when it closed at $7.84
--On pace for largest percent increase since Aug. 12, 2025, when it rose 30.58%
--Currently up two consecutive days; up 31.43% over this period
--Best two day stretch since the two days ending Aug. 13, 2025, when it rose 33.5%
--Up 13.62% month-to-date
--Up 129.69% year-to-date
--Down 87.69% from its all-time closing high of $60.62 on Aug. 20, 2021
--Up 203.46% from 52 weeks ago (Aug. 20, 2025), when it closed at $2.46
--Would be a new 52-week closing high
--Up 220.39% from its 52-week closing low of $2.33 on Aug. 27, 2025
--Traded as high as $7.70; highest intraday level since Nov. 7, 2024, when it hit $8.14
--Up 34.15% at today's intraday high; largest intraday percent increase since Feb. 23, 2024, when it rose as much as 68.69%
All data as of 10:31:49 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 19, 2026 10:36 ET (14:36 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin Presents Both Danger and Opportunity! ETFs Are Strengthening, But This Data Is Alarming!
XRP Traders Target $1.90 as On-Chain Ledger Value Expands 43 Times to $4.26 Billion

Following Novartis, Novo Nordisk (NVO.US) terminates two cardiovascular clinical trials.
Novo Nordisk (NVO.US) has terminated two additional clinical trials of its experimental cardiovascular drug.

Saudi Oil facilities hit in fresh strikes, WTI surges above $90